Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 1 15Phase 3 5Phase NA 4Phase 1/2 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 20Gynecologic 17Gastrointestinal 17Thoracic 11Genitourinary 5CNS 5Sarcoma 4Other solid neoplasm 2Breast 2Tumor-Agnostic 1Plasma cell 1Lymphoid 1

Conditions

Osteosarcoma 3Sarcoma 1

Interventions

Magnetic Resonance Spectroscopy 13Ifosfamide 12Doxorubicin 12Blood Specimen Collection 12Radiotherapy 11Methotrexate 10fludarabine phosphate 9Surgical Procedures, Operative 9Radiosurgery 9Cyclophosphamide 9Surveys and Questionnaires 8Cyclosporine 8Proton Therapy 7Peripheral Blood Stem Cell Transplantation 7Busulfan 7Mycophenolic Acid 6Melphalan 6Whole-Body Irradiation 5Standard of Care 5Filgrastim 5Etoposide 5Early Intervention, Educational 5Carboplatin 5Biopsy 5Antilymphocyte Serum 5Vincristine 4Temozolomide 4Sunitinib 4Radiation Dose Hypofractionation 4Mesna 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Cisplatin × Sarcoma × Clear all
NCT03909776 2021-01-05

Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma

Peking University People's Hospital

Phase NA Completed
99 enrolled
Sarcoma

Osteosarcoma

NCT03360760 2018-08-28

Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum

Peking University People's Hospital

Phase NA Unknown
100 enrolled
Sarcoma

Osteosarcoma

NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

M.D. Anderson Cancer Center

Phase NA Terminated
7 enrolled 3 charts
Sarcoma

Osteosarcoma

NCT00645632 2011-05-16

Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma

Mayo Clinic

Phase NA Completed
60 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡